Company: GIFLF
Filing Date: 2025-04-11
Form Type: 20-F
Source: 0001104659-25-034245
Chunk: 5

Company: Grifols SA
Filing Date: 2025-04-11
Form: 20-F
Item: Item 3
Chunk 5
---
 involving the personal information of our plasma or blood donors) could disrupt our business and expose us to significant losses, liability and reputational damage;
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

●   Our success depends in large part on our ability to obtain and maintain protection in the United States and other countries of the intellectual property relating to or incorporated into our technology and products;
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

●   In addition to patented technology, we rely on our unpatented proprietary technology, trade secrets, processes and know-how;
--------------------------------------------------------------------------------------------------------------------------------

●   We may infringe or be alleged to infringe intellectual property rights of third parties;
--------------------------------------------------------------------------------------------

●   We have in-licensed certain patent rights and co-own certain patent rights with third parties;
--------------------------------------------------------------------------------------------------

●   We may not realize the expected benefits from the entry into new or amended contracts, cost-savings and business improvement initiatives;
---------------------------------------------------------------------------------------------------------------------------------------------

●   Climate change and increased risk of major natural disasters may adversely affect our business; and
-------------------------------------------------------------------------------------------------------

●   Changes, enactment, and/or enforcement of biometric information privacy laws of different jurisdictions, including federal and state laws in the United States, could expose us to potential liability.
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Risks Relating to the Healthcare Industry:

●   United States Healthcare Reform may adversely affect our business;
----------------------------------------------------------------------

●   Government pressures and constraints on reimbursement may adversely affect our business;
--------------------------------------------------------------------------------------------

●   Impact of government regulations over product development and regulatory approvals, as well as government pressures and constraints on reimbursement may adversely affect our business;
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

●   Failure to comply with laws and regulations governing the sales and marketing of our products or an adverse decision in lawsuits may result in adverse consequences to us;
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

●   We could be adversely affected if other government or private third-party payors decrease or otherwise limit the amount, price, scope or other eligibility requirements for reimbursement for the purchasers of our products;
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

●   We are subject to extensive government regulatory compliance and ethics oversight;
--------------------------------------------------------------------------------------

●   Failure to comply with changing regulatory requirements could materially adversely affect our business; and
---------------------------------------------------------------------------------------------------------------

●   We are subject to extensive environmental, health and safety laws and regulations.
--------------------------------------------------------------------------------------
4

Risks Relating to Our Shares and American Depositary Shares:

●   If we discover material weaknesses or significant deficiencies in our internal control over financial reporting, it may adversely affect our ability to provide timely and reliable financial information and satisfy our reporting obligations under U.S. federal securities laws, which also could affect the market price of our American